Weiner, H L <br/><br/>
Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.  [electronic resource] 

 -  Annals of neurology  Oct 2000 
 - 567-79 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Intranasal<br/>Alzheimer Disease--drug therapy<br/>Amyloid--analysis<br/>Amyloid beta-Peptides--administration & dosage<br/>Analysis of Variance<br/>Animals<br/>Brain--drug effects<br/>Brain Chemistry<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Humans<br/>Immunohistochemistry<br/>Mice